Galanthamine-N-oxide is primarily explored for its potential therapeutic applications, particularly in the field of neuroscience. It is studied for its role in modulating cholinergic activity, which is crucial for cognitive functions. Research suggests it may have applications in treating neurodegenerative disorders such as Alzheimer's disease, where enhancing cholinergic transmission can help alleviate symptoms of memory loss and cognitive decline. Additionally, it is investigated for its antioxidative properties, which could contribute to neuroprotection by reducing oxidative stress in brain tissues. Its potential use in improving synaptic plasticity and neuronal communication is also a focus of ongoing studies.